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86a Sunday, March 6, 2011account for either the ability of aCaMKII to self-associate or bCaMKII to be
unable to self-associate. Identification of these mutations that disrupt self-asso-
ciation and still allow targeting affords the opportunity to definitively deter-
mine the role that self-association plays in the subcellular localization of
CaMKII during physiological and pathological conditions.
461-Pos Board B261
Nucleobindin 1 is a Calcium Regulated Guanine Nucleotide Dissociation
Inhibitor of GI1
Neeraj Kapoor, Ruchi Gupta, Santosh T. Menon, Ewa folta-Stogniew,
Daniel P. Raleigh, Thomas P. Sakmar.
Nucleobindin 1 (NUCB1) is a widely expressed multi-domain calcium-binding
protein whose precise physiological and biochemical functions are not well un-
derstood. We engineered and heterologously expressed a soluble form of
NUCB1 (sNUCB1) and show that sNUCB1 exists as a Calcium binding dimer
in solution and binding to Calcium causes conformational changes in sNUCB1.
Earlier reports suggested that NUCB1might interact with heterotrimeric G pro-
tein a subunits. We show that dimeric sNUCB1 binds to Gai1 and that calcium-
binding inhibits the interaction. The binding of sNUCB1 to Gai1 inhibits its
basal rate of GDP release and slows its rate and extent of GTPgS uptake. Ad-
ditionally, our tissue culture experiments show that
sNUCB1 prevents receptor-mediated Gai-depen-
dent inhibition of adenylyl cyclase (AC). Thus,
we conclude that sNUCB1 is a calcium dependent
guanine-nucleotide dissociation inhibitor (GDI)
for Gai1. To our knowledge sNUCB1 is the first
example of a calcium-dependent GDI for heterotri-
meric G proteins. We also show that the mecha-
nism of GDI activity of sNUCB1 is unique and
does not arise from the consensus Goloco motif
found in RGS proteins. We propose that cytoplas-
mic NUCB1 might function to regulate heterotri-
meric G protein trafficking and signalling.
462-Pos Board B262
Conformational Dynamics in Dream Protein
Jaroslava Miksovska.
Downstream Regulatory Element Antagonist Modulator (DREAM), also
known as calsenilin or Kþ channel interacting protein 3 (KChIP-3) belongs
to neuronal calcium sensor proteins that are found predominantly in neuronal
cells where they regulate diverse aspects of neuronal function ranging from
neurotransmitter release to neuronal growth and apoptosis. DREAM is a highly
multifunctional protein that binds to presenilin, acts as a transcriptional repres-
sor for a number of genes including c-fos gene and prodynorphin gene in Ca2þ
dependent manner, and interacts and modulates the activity of A-type of Kþ
channels. To obtain insight into the Ca2þ signaling mechanism, the
impact of binding of metals and DNA on conformational heterogeneity and
dynamic motion of DREAM was probed using steady-state and time-
resolved fluorescence and anisotropy techniques. In addition the role of the
individual EF-hands




mutants with the im-
paired EF-hand 3
and EF hand 4.463-Pos Board B263
The Interaction of S100a1 with Type-2b Regulatory Subunit of Protein
Kinase A
Brian Cannon, Erick Herna´ndez-Ochoa, Kristen Varney, Martin Schneider,
David Weber.
The S100 family of proteins consists of 24 calcium-activated signaling mole-
cules that are involved in a variety of biological processes. They are expressed
exclusively in vertebrates in a tissue-specific manner. One member of this fam-
ily, S100A1, is involved in several biological processes. In the heart, S100A1
has been shown to be essential for cadiac function (Pleger et al, 2007). In skel-
etal muscle, S100A1 is known to help modulate excitation-contraction cou-
pling through interaction with the ryanodine receptor (Prosser et al, 2008).
Furthermore, in ganglion neurons exogenous S100A1 increases sympathetic
output by enhancing Cav1 channel currents (Herna´ndez-Ochoa et al, 2009).
This effect is occluded by the inhibition of PKA, suggesting a PKA-dependence
of this process. Our laboratory has now used ITC and NMR to demonstrate that
S100A1 interacts with the type-2b regulatory subunit of PKA.464-Pos Board B264
Differential Activation of Intracellular Calcium Oscillations by Multiple
Calcium and L-Phenylalanine Binding Sites Located at the Extracellular
Domain of Calcium-Sensing-Receptor
Chen Zhang, Yun Huang, Yusheng Jiang, Hing Wong, Xue Wang,
Adriana Castiblanco, Ling Wei, Edward Brown, Jenny J. Yang.
Calcium sensing receptor (CaSR), along other members of the family C G pro-
tein-coupled receptors (GPCRs), play very important roles in responding to
changes in the extracellular calcium concentrations and in circulating levels
of amino acids and integrating these extracellular signals into alterations in
intracellular signaling pathways. We have reported several potential calcium-
binding sites located within the CaSR’s extracellular domain using our
developed computational algorithms based on geometric factors and surface
electrostatic potentials. In the present study, we first report the differential ef-
fects of several disease-related mutations located at the predicted calcium bind-
ing sites on the inhibition and activation of intracellular calcium responses
using both a cell population assay and single cell imaging. We then identify
a potential amino acid binding site using computational methods and site-di-
rected mutagenesis. The effect of amino acid binding in altering intracellular
calcium responses, especially calcium oscillations, and its synergistic interac-
tion with the effects of extracellular calcium on these parameters are also inves-
tigated. A common activation mechanism for CaSR and other family C GPCRs,
such as mGluR1 by extracellular calcium and amino acid is been proposed.
These results could have important implications for our understanding of
how the CaSR integrates information about these two completely different clas-
ses of agonists–one an inorganic divalent cation, the other a nutrient–and how
the receptor senses these agonists in health and in disease states.
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Living on the Edge: Mechanisms of Single Cell Responses at Air-Liquid
Interfaces
Nina Hobi, Andrea Ravasio, Thomas Haller.
Many epithelia have contact with air-liquid interfaces. This applies particularly
to the lung, where one of the epithelial cell types, the surfactant secreting AT II
cells, even project into the air-filled alveolar lumen. This specific environment
may be of considerable physiological relevance; however, only few data exist
to provide a satisfying description. This is mainly due to the experimental
difficulty to manipulate cell-air contacts in a specific way. In previous investi-
gations, using new microscopic approaches, we found that the presence of an
air-liquid interface leads to a paradoxical situation: it is a potential threat that
causes cell injury, but also a potent stimulus: AT II cells respond promptly,
and show sustained Ca2þ-signals that activate exocytosis. Exocytosed surfac-
tant, in turn, clearly prolonged the time to irreversible cell damage, and may
be an adaptive defense against the harmful nature of surface forces. The
strength of this stimulus became also apparent by a rapid and significant change
on the transcriptional level: cellular pathways that are involved include e.g. de-
fense response and lipid metabolism, and a Pubmatrix search identified genes
associated with several lung diseases and injuries. Furthermore, we found
that the signalling mechanisms underlying sensation of an air-liquid interface
can be sufficiently explained by mechanical forces. These forces trigger cellular
events that are closely related with classical concepts in mechanotransduction.
In conclusion, we suggest that an air-liquid interface has to be regarded as a spe-
cialized form of an extracellular matrix. This matrix, probably an important
constraint in the evolution of air-exposed biological surfaces, exerts distinct
physical stimuli which are very well perceived by the cells.
466-Pos Board B266
Electrodiffusion and Osmotic Water Flow and its Variational Structure
Yoichiro Mori, Chun Liu, Robert S. Eisenberg.
We propose a system of partial differential equations (PDE) that describe
electrodiffusion and osmotic water flow. From a physical standpoint, this is
a far-reaching generalization of the standard treatment of osmosis and electro-
diffusion in irreversible thermodynamics to spatially extended systems. As far
as we know, this is the first mechanically and thermodynamically consistent
model of osmotic water flow and electrodiffusion in systems with deformable
cells and membranes with capacitance and conductance. We use an energetic
variational approach to enforce consistency and derive a field theory describing
the flow, diffusion, and migration of ions, water, and the solution itself. The
variational approach is particularly useful because it treats interactions auto-
matically and consistently with a minimal number of arbitrary parameters.
Electrodiffusion and osmotic water flow are involved in a wide range of biolog-
ical functions of organs, tissues, cells, and organelles, including the homeosta-
sis of ions in the brain, fluid secretion by epithelial systems, electrolyte
Sunday, March 6, 2011 87aregulation in the kidney, fluid circulation in ocular systems, gastric protection,
water uptake by plants, etc. The field equations can be written with boundary
conditions and parameters appropriate for the anatomy of each system. The
field equations then form a physically and anatomically consistent model of bio-
logical function in the variational framework of modern field theory. The varia-
tional approach deals naturally with the many ionic solutions (containing
a multitude of interacting components in a wide range of concentrations) and
the wide range of conditions and forces used in experiments. Solving the PDEs
will help suggest and interpret new experiments to understand the interaction
of components, conditions, structure, and forces. In the view of classical physiol-
ogy and biophysics, these interactions are the essence of biological function.
467-Pos Board B267
Revisiting the Heteromultimeric Structure of ENaC in XENOPUS Leavis
Oocytes
Rosanna De Nuccio, Miguel van Bemmelen, Ivan Gautschi, Laurent Schild.
The functional epithelial sodium channel (ENaC) is a heteromeric channel
formed by three homologous alpha, beta and gamma subunits.
Several functional and biochemical studies have provided evidence that the
ENaC is a heterotetramer formed by 2alpha, 1beta and 1gamma subunits. Re-
cently, a high-resolution crystal structure has been obtained from an ortholog of
ENaC, the acid-sensing ion channel ASIC1, which showed a homotrimeric
channel. This discrepancy between two channels of the same ion channel fam-
ily, motivated us to revisit the subunit oligomerization of ENaC.
His-tagged ENaC alpha, beta and gamma subunits were expressed in Xenopus
leavis oocytes. The three ENaC subunits can be co-purified on Niþ2-NTA aga-
rose beads in an alpha beta gamma-ENaC complex. OnWestern blot, the ENaC
subunits showed typical post-translation modifications associated with a func-
tional channel. Using differentially tagged ENaC subunits, we investigated
whether the ENaC complex contains more than a single alpha, beta or gamma
subunits. Two differentially tagged alpha subunits co-purified with beta and
gamma subunits, indicating that ENaC is formed by more than one alpha sub-
unit. The purified ENaC complex channel eluted on Sephadex G 200 column in
a fraction corresponding to a molecular weight of 350 kDa, which was higher
than expected for a alpha beta gamma-ENaC.
These data confirm previous reports that the functional ENaC channel is a het-
erotetramer made of 2alpha 1beta, and 1gamma subunits.
468-Pos Board B268
xshroom1 Regulates the Number of ENaC Channels Inserted in the Mem-
brane of Oocytes From XENOPUS Laevis
Yanina A. Assef, Luciano Galizia, Gabriela I. Marino, Basilio A. Kotsias.
Shroom is a family of proteins linked to the actin cytoskeleton. We studied its
effect upon the currents through ENaC channels (INa amil) in oocytes (X. laevis)
injected with a, b, and g mENaC and xShroom1 sense or antisense oligonucle-
otides. We observed a strong reduction in INa amil with the xShroom1 antisense:
inward conductances (Ginward) (160 to 0 mV) were 36 5 12 mS and
1.80 5.50 mS with xShroom1 sense and antisense. Similar results were
obtained in oocytes expressing a mutant b-mENaC subunit (b-S518K) with
a open probability of 1 (Ginward 65 5 10 mS and 1.80 5 2.0 mS for oocytes
with xShroom1 sense or xShroom1 antisense. The negative effects of xShroom1
antisense can not be reversed with forskolin which reduced the rate of ENaC
retrieval: Ginward : 124 5 27 mS and 7.0 5 1.9 mS with xShroom1 sense or
xShroom1 antisense. Trypsin in the range of ng/ml activates the membrane-res-
ident ENaC channels (Bengrine et al.2007), being this effect dependent on acti-
vation ofG-proteins.Addition of 20 ng/ml of trypsin led to a slow increase in INa
amil with xShroom1 sense and it had no effect in most of the oocytes coinjected
with ENaC and xShroom1 antisense (2 out of 20). Trypsin were without effects
on the endogenous conductances. These data are consistent with the idea that the
reduced INa amil when xShroom1 is blocked is most probably due to a lack of
functional ENaC channels in the plasma membrane.
Acknowledgements: ENaC cDNAs were provided by Dr M. Carattino (Pitts-
burgh, Pa). and the set for oocytes was a gift of Dr C. Peracchia (Rochester,
NY). Supported by grants MO35 (UBA) and PICT 38181.
469-Pos Board B269
Synthetic Peptide-Based Channels: Candidates for Treatments
of Channelopathies
Urska Bukovnik, Monica Sala-Rabanal, Colin Nichols, Bruce Schultz,
Jianhan Chen, John Tomich.
Modern approaches for treatments of channelopathies employ mutation-spe-
cific pharmacotherapies, use pharmacoagents alone, or a vast variety of ideas
for genetic approaches, all with the purpose of restoring defective ion chan-
nels or attenuate their negative effects. An alternative to existing approachesis the use of synthetic channel-forming peptides (CFPs) with desirable selec-
tivity, high ion transport rates and overall ability to supersede defective en-
dogenous ion channels. Our synthetic CFPs represent derivatives of
a peptide initially reconstituted from the second transmembrane segment of
the a-subunit of Glycine receptor (M2GlyR), PARVGL-
GITTVLTMTTQSSGSRA. Due to poor efficiency of membrane insertion,
tendency to form aggregates in aqueous solutions and inconsistent channel
forming potentials, parent peptide sequences were modified to alter chan-
nel-inducing properties. Resulting NK4-M2GlyR T19R, S22W, with two thre-
onines replaced by a non-natural amino acid, diamino propionic acid (Dap)
(NK4-M2GlyR T19R, S22W, TT-Dap) represent our best candidates. We ex-
amined potential channel pore-lining residues using molecular dynamics stud-
ies followed by the sulfhydryl replacement technique. Identified residues
involved in ion selectivity filter seem to represent a ring of b-hydroxyls
from the threonines at position 17 and 13. Ussing chamber experiments em-
ploying MDCK cells and voltage-clamp studies using Xenopus oocytes re-
vealed that introduction of Dap substitutions at pore-lining residues yields
improved channel conductances. In conclusion, in addition to their ability
to form soluble monomers in aqueous solutions, ability to self-assemble
into homopentamers, efficient delivery to and insertion into the membranes
of tested MDCK cells, NK4-M2GlyR T19R, S22W, TT-Dap peptides show
enhanced ion transport activities at low peptide concentration compared to
their parent sequence (NK4-M2GlyR T19R, S22W).
470-Pos Board B270
Molecular Modeling and Simulation of a Synthetic Peptide Channel
Jian Gao, John Tomich, Jianhan Chen.
Many human diseases, including episodic ataxia, diabetes, epilepsy, cystic fi-
brosis and Alzheimer’s dementia, are related to defective ion channels. A se-
ries of channel forming peptides derived from the second transmembran
domain of the a1-subunit of the glycine receptor (M2GlyR) have been de-
signed by the Tomich lab with improved anion conduction rate and aqueous
solubility. To rationally understand the physiological properties of these syn-
thetic channels and to identify improved designs, we combine NMR, biophys-
ical data, and molecular modeling to provide a structural basis for
understanding key physiochemical properties that govern the chloride conduc-
tivity and selectivity. Initial structural models were first constructed for one of
our lead design, p22-T19R/S22W (KKKKP ARVGL GITTV LTMRT QW),
primarily based on the monomer structure from solution NMR, amphipathicity
consideration, and the oligomeric state of the channel assembly. Long molec-
ular dynamic simulations in explicit membrane and water were then carried out
to characterize the channel structural and dynamic properties. Interestingly, in-
dependent simulations from initial constructs with different handiness of helix
packing (left, straight, and right) all converge to a similar structural ensemble
with left-handed helix assembly. The predicted pore-lining residues are also in
excellent agreement with a previous set of cysteine-scanning experiments.
Coupled with parallel experimental characterizations in the Tomich lab, the
simulation provides important insights into the structural basis of the activity
of these synthetic channels.
471-Pos Board B271
Two Genetic Variants of TRPM6 Increase Risk for Hypomagnesemia
Associated with Diabetes Mellitus Type 2
Anil Nair, Berthold Hocher, Thiemo Pfab, Martin Konrad,
Femke Van Zeeland, Rene´ Bindels, Joost Hoenderop.
Diabetes mellitus type 2 (DM2) is characterized by high serum glucose levels,
insulin resistance and hypomagnesemia. DM2-related hypomagnesemia has
been linked to several chronic diabetic complications. Transient receptor poten-
tial melastatin 6 (TRPM6) channel plays an essential role in whole body Mg2þ
homeostasis. It has been suggested by conducting nested case control study that
two non-synonymous single nucleotide polymorphisms (SNP) of TRPM6,
TRPM6(V1393I) & TRPM6(K1584E) might increase risk for DM2 in elderly
women. Here, by measuring Total Glycosylated Hemoglobin (TGH) from 997
women in their last weeks of pregnancy as a measure of glucose control, we
show that the two SNPs (6.8 %) have higher TGH compared to control subjects
(6.3 %). Upon overexpression in a human kidney cell line, whole-cell patch
clamp analysis showed that insulin activates (EC50 = 0.16 nM) TRPM6, but
not the SNPs. Inability to phosphorylate T1391 was the identified factor for
lack of insulin-mediated V1393I activation. We further demonstrate that
TRPM6 stimulation is independent of its own kinase activity, but relied on
both Phosphoinositide 3-kinase and Rac1. The impaired response of the
SNPs to insulin may lead to hypomagnesemia causing insulin resistance. These
SNPs could be used as markers to improve diagnosis and identify those at risk
for developing DM2.
